LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-17
Case ID: NM_006005.3_c.1675G_A_20261117_013359
Framework: ACMG/AMP 2015
Variant classification summary

NM_006005.3:c.1675G>A

WFS1  · NP_005996.2:p.(Ala559Thr)  · NM_006005.3
GRCh37: chr4:6303197 G>A  ·  GRCh38: chr4:6301470 G>A
Gene: WFS1 Transcript: NM_006005.3
Final call
VUS
All criteria require review: For research and educational purposes only.
Gene
WFS1
Transcript
NM_006005.3
Protein
NP_005996.2:p.(Ala559Thr)
gnomAD AF
0.00485437495194609 (v4.1)
ClinVar
Likely benign
OncoKB
Interpretation summary
Generated evidence synthesis
1
No patient-specific parental testing, de novo observation, affected-relative segregation, or affected-relative non-segregation evidence was supplied; all four criteria remain not assessed.
2
No VCEP covers WFS1 in this case; generic ACMG/AMP 2015 definitions govern.
3
PS4 could not be numerically assessed because verified case-control counts or an OR/RR with a confidence interval were unavailable.
4
PP5 and BP6 were not met because the exact ClinVar record has no expert-panel classification; its benign/likely benign laboratory assertions are insufficient for these restricted rules.
Final determination: Generic ACMG/AMP 2015 fallback rules do not meet any pathogenic, likely pathogenic, benign, or likely benign combination threshold because no criterion is applied, so the final call is VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not assessed Not assessed: A559T was reported but not established as pathogenic, and the exact ClinVar record contains benign or likely benign submissions.
clinvar PMID:12565131
PS2 Not assessed Not assessed: no documented patient-specific de novo observation confirms both maternity and paternity for NM_006005.3:c.1675G>A.
PS3 Not assessed Not assessed: no variant-specific well-established functional study provides a damaging-effect result for WFS1 p.Ala559Thr.
PS4 Not assessed Not assessed: no verified affected-versus-control counts, odds ratio, or confidence interval were available for c.1675G>A, so the PS4 >5.0 and CI-excluding-1.0 requirements cannot be evaluated.
PM1 Not assessed Not assessed: Cancer Hotspots returned no WFS1 A559 result, while no authoritative WFS1 critical-domain list is available for residue 559.
hotspots
PM2 Not met Not met: gnomAD v4.1 AF is 0.00485437, substantially above the <=0.0001 PM2 supporting threshold, with 20 homozygotes observed.
gnomad_v2 gnomad_v4
PM3 Not assessed Not assessed: no affected-proband observation documents c.1675G>A in trans with a pathogenic WFS1 variant or establishes phase by parental or offspring testing.
clinvar
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not assessed Not assessed: no pathogenic alternate missense at Ala559 is established, and the PM5 candidate collection contains zero same-residue candidates.
pm5_candidates PMID:12565131
PM6 Not assessed Not assessed: no patient-specific observation documents NM_006005.3:c.1675G>A as assumed de novo without parental confirmation.
PP1 Not assessed Not assessed: 0 affected family-member transmissions or informative meioses are documented for NM_006005.3:c.1675G>A.
PP2 Not assessed Not assessed: the required WFS1 gene-level evidence for low benign missense variation and a common missense disease mechanism is unavailable.
PP3 Not met Not met: REVEL 0.407 is below the PP3 supporting threshold of 0.644.
revel
PP4 Not assessed Not assessed: the supplied evidence lacks a patient phenotype or family-history description demonstrating high specificity for a single-genetic-etiology disease.
PP5 Not met Not met: ClinVar has zero expert-panel submissions and reports benign/likely benign assertions, not an expert-panel pathogenic or likely-pathogenic classification.
clinvar
BA1 Not met Not met: gnomAD v4.1 grpmax FAF is 0.0055781, below the 0.05 BA1 threshold, in a population with 1,180,036 observed alleles.
gnomad_v2 gnomad_v4
BS1 Not met Not met: default gnomAD v4.1 grpmax FAF is 0.0055781, below the generic BS1 threshold of 0.01 despite adequate population size.
gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: gnomAD v4.1 reports 20 homozygotes, but no record establishes that any was a healthy adult with expected early full penetrance.
gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no variant-specific well-established functional study shows that WFS1 p.Ala559Thr has no damaging effect.
BS4 Not assessed Not assessed: 0 tested affected relatives are documented as lacking NM_006005.3:c.1675G>A, so non-segregation cannot be established.
BP1 Not assessed Not assessed: the available evidence does not establish that WFS1 disease is caused primarily by truncating variants.
BP2 Not assessed Not assessed: no individual-level observation establishes c.1675G>A in cis or trans with a pathogenic WFS1 variant, and no phase result is documented.
clinvar
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: REVEL 0.407 exceeds the BP4 supporting threshold of <=0.29.
revel
BP5 Not assessed Not assessed: no case-level alternate molecular diagnosis or pathogenic alternative explanation was supplied for a carrier of c.1675G>A.
BP6 Not met Not met: ClinVar's benign/likely benign record has zero expert-panel submissions, so non-expert laboratory assertions cannot trigger BP6.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.